Study shows reversible switch for targeted cytokine delivery

Agency clarifies UK pathway for emerging therapies

Priority review granted for first‑in‑class Tourette therapy

First guidance for a licensed hyperhidrosis treatment

Company receives USD 10 million upfront

Partnership expands access to men’s health treatment

Saffron trial delivers positive results

Phase 3 study shows strong efficacy

Rigel makes Veppanu available across US

Study begins testing KJ‑103 in TROP2‑positive cancers